Pronounced dys-autonomic symptoms announcing a primary Sjögren’s syndrome
Submitted: 24 July 2019
Accepted: 20 May 2020
Published: 23 July 2020
Accepted: 20 May 2020
Abstract Views: 1021
PDF: 631
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Muller, S. Hider, T. Helliwell, R. Partington, C. Mallen, The real evidence for polymyalgia rheumatic as a paraneoplastic syndrome , Reumatismo: Vol. 70 No. 2 (2018)
- A. Minelli, A. Vaona, Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review , Reumatismo: Vol. 64 No. 3 (2012)
- S. Muller, S. Hider, T. Helliwell, R. Partington, C. Mallen, The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome , Reumatismo: Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
- A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi, In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation , Reumatismo: Vol. 64 No. 1 (2012)
- C. Giacomelli, R. Talarico, C. Baldini, L. Bazzichi, Pain in Sjögren’s syndrome , Reumatismo: Vol. 66 No. 1 (2014)
- A. Alunno, V. Caneparo, F. Carubbi, O. Bistoni, S. Caterbi, M. Gariglio, E. Bartoloni, S. Landolfo, R. Gerli, Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: findings in serum and minor salivary glands , Reumatismo: Vol. 67 No. 3 (2015)
- A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli, Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity , Reumatismo: Vol. 64 No. 5 (2012)
- F. Salaffi, A. Ciapetti, P. Sarzi Puttini, F. Atzeni, C. Iannuccelli, M. Di Franco, M. Cazzola, L. Bazzichi, Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience , Reumatismo: Vol. 64 No. 1 (2012)
- J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam, Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome , Reumatismo: Vol. 67 No. 2 (2015)
- F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò, Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center , Reumatismo: Vol. 70 No. 2 (2018)
You may also start an advanced similarity search for this article.